Dexrazoxane preferentially mitigates doxorubicin cardiotoxicity in female children with sarcoma.
Narayan HK, Putt ME, Kosaraju N, Paz A, Bhatt S, Plappert T, Mercer-Rosa L, Armenian SH, Desai AV, Womer RB, Ky B.
Narayan HK, et al. Among authors: ky b.
Open Heart. 2019 Jun 24;6(1):e001025. doi: 10.1136/openhrt-2019-001025. eCollection 2019.
Open Heart. 2019.
PMID: 31297226
Free PMC article.